Approval · Notice of Compliance 8264 · 2006
MUSTARGEN: Notice of Compliance 8264
Issued September 14, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8264
- Date
- September 14, 2006
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Alkylating agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MUSTARGEN | 00016063 | Cancelled Post Market |
Medicinal ingredients
- MECHLORETHAMINE HCL 10 MG per VIAL